CASCADE BIOSYSTEMS, INC.

Medtech · Private

isothermal DNA detection device for malaria diagnostics using restriction cascade exponential amplification (RCEA)

cascadebiosystems.com →
Grants
$150K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
30
17 granted · 13 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Highly sensitive isothermal method and instrument for field diagnostics to facilitate malaria eradication$150,000
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2273Precede Biosciences——
2274IN SITU THERAPEUTIC SOLUTIONS, INC.——
2275THERAPEUTIC BANDAGE PRODUCTS LLC——
2276CASCADE BIOSYSTEMS, INC.——
2277MASSACHUSETTS NEURO TECHNOLOGY, INC.——
2278Frontier Diagnostics, LLC——
2279GLYCODOTS, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 17 granted of 30

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.